Back to Agenda
Regulatory Sandbox
Session Chair(s)
Francois Hebraud, PHARMD
EU Regulatory Policy Lead, Roche, Switzerland
Falk Ehmann, MD, PHD, MS
Head of Innovation and Development Accelerator, Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Regulatory Sandbox
Learning Objective : Participants will get a better understanding of the mechanism, conditions to ensure its effectiveness and sustainability and its place within the reg toolbox, including perspectives and opinions on the opportunities and challenges from legislators, regulators, industry and potentially other stakeholders.
Speaker(s)
Francois Hebraud, PHARMD
EU Regulatory Policy Lead, Roche, Switzerland
Regulatory Sandbox - Is Europe Ready to Take Full Advantage of This Adaptive Tool?
Falk Ehmann, MD, PHD, MS
Head of Innovation and Development Accelerator, Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Understanding the Sandbox Concept for Exploration of New Approaches
Lamine Messaoudi, DVM, MS
Head Of EUCAN Regulatory Policy And Innovation, Takeda Pharmaceuticals International Gmbh, Switzerland
The Industry Perspective
Julie Spony, MA
Policy Officer, European Patients' Forum, Belgium
Panelist
Johanne Veenstra
A/Drug GMP Specialist,, Health Canada, Canada
Have an account?